The Annual Meeting of Shareholders in Novozymes A/S took place yesterday, with the report on the company's activities in the last financial year being adopted. The Annual Meeting also approved the following items: • the audited annual report, including the resolution on discharge of the Management and Board of Directors • resolution on appropriation of profit in accordance with the adopted financial statements (annual report), with a dividend of DKK 4.50 being paid per share of DKK 10 • re-election of the six members of the Board of Directors elected by the Annual Meeting of Shareholders, and enlargement of the Board with the first-time election of Professor Mathias Uhlén, Royal Institute of Technology, Stockholm • re-election of PricewaterhouseCoopers • resolution to change the wording of Section 8.2 of the Articles of Association as follows: ”Annual Meetings of Shareholders are held in the metropolitan region, as specified by the Board of Directors.” • authority for the Board of Directors, in the period until the next Annual Meeting of Shareholders, to acquire treasury shares equivalent to 10% of the share capital at the share price on the date of acquisition, subject to a permitted price difference of up to 10%, cf. Section 48 of the Danish Public Companies Act For full report please see attached PDF-file..